查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566925

軟體作為醫療設備市場：按部署類型、應用程式和最終用戶：2024-2033 年全球機會分析和產業預測

Software as a Medical Device Market By Deployment Type , By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 233 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

(SaMD) 軟體作為醫療設備市場

2023 年，軟體即醫療設備(SaMD) 市場價值為 1,950 萬美元，預計 2024 年至 2033 年複合年成長率為 17.3%，到 2033 年將達到 9,620 萬美元。

軟體即醫療設備(SaMD) 是專為醫療用途而設計的專用軟體，無需硬體醫療設備即可執行功能。 SaMD 幫助管理患者健康資料、診斷健康狀況並推薦治療方法。該軟體用途廣泛且易於使用，因為它可以在智慧型手機和平板電腦等通用運算平台上輕鬆存取。 SaMD 的主要特點是其獨特地實現醫療目標的潛力，從而加速現代醫療保健系統的範圍和效率。

遠端醫療和遠端患者監護的日益普及是軟體即醫療設備(SaMD) 市場的關鍵促進因素。此外，食品藥物管理局和歐盟等多個監管機構的支持正在推動對 SaMD 的需求。為了更好地支援醫療保健提供者，整合臨床決策支援系統 (CDSS) 是市場上的新興趨勢。 CDSS 功能有助於基於證據的臨床決策，提高診斷準確性並最佳化治療程序。

然而，將現有醫療記錄和醫療保健資料整合到 SaMD 中既耗時又昂貴，阻礙了軟體即醫療設備(SaMD) 市場的開拓。此外，該軟體的使用必須遵守美國食品藥物管理局(FDA) 的嚴格監管，這給 SaMD 開發人員帶來了重大挑戰。 FDA 監管要求包括上市前核准、嚴格的品質檢查、上市後監督、網路安全要求以及某些軟體修復和更新。所有這些要求確保了SaMD的可靠性和有效性，並防止關鍵醫療資料和患者記錄的洩露。

分部審查

軟體即醫療設備(SaMD) 市場分為部署類型、應用程式、最終用戶和區域。根據部署類型，市場分為基於雲端基礎和本地市場。依應用分為篩檢與診斷、監測與警報、慢性病管理、數位治療等。依最終使用者分類，可分為醫院/診所、居家照護環境等。從區域來看，分析包括北美、歐洲、亞太地區和拉丁美洲地區。

主要發現

從部署類型來看，雲端基礎的細分市場在醫療設備軟體市場中佔據主導地位。

從應用來看，篩檢診斷領域佔有較高的市場佔有率。

從最終用戶來看，醫院和診所佔有很高的佔有率。

按地區分類，北美在 SaMD醫療設備市場中收益最高。

可使用此報告進行客製化（需要額外費用和時間表）

  • 監管指引
  • 根據客戶興趣新增其他公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 公司簡介的擴充列表
  • 歷史市場資料
  • 主要參與者的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 主要投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第 4 章 軟體作為醫療設備(SAMD) 市場：依部署類型

  • 市場概況
  • 雲端基礎
  • 本地

第 5 章 軟體作為醫療設備(SAMD) 市場：依應用分類

  • 市場概況
  • 篩檢和診斷
  • 監控和警報
  • 慢性病管理
  • 數位療法
  • 其他

第 6 章 軟體作為醫療設備(SAMD) 市場：依最終使用者分類

  • 市場概況
  • 醫院和診所
  • 居家醫療
  • 其他

第 7 章 軟體即醫療設備(SAMD) 市場：依地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國：軟體即醫療設備(SaMD) 市場
    • 加拿大軟體醫療設備(SaMD) 市場
    • 墨西哥的軟體即醫療設備(SaMD) 市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 德國軟體即醫療設備(SaMD) 市場
    • 法國軟體醫療設備(SaMD) 市場
    • 英國軟體即醫療設備(SaMD) 市場
    • 義大利軟體即醫療設備(SaMD) 市場
    • 西班牙軟體即醫療設備(SaMD) 市場
    • 其他歐洲國家軟體如醫療設備(SaMD) 市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 日本的軟體即醫療設備(SaMD) 市場
    • 中國軟體醫療設備（SaMD）市場
    • 印度軟體醫療設備(SaMD) 市場
    • 澳洲軟體醫療設備(SaMD) 市場
    • 韓國軟體醫療設備(SaMD) 市場
    • 其他亞太地區軟體即醫療設備(SaMD) 市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西的軟體即醫療設備(SaMD) 市場
    • 沙烏地阿拉伯軟體作為醫療設備(SaMD) 市場
    • 南非：軟體即醫療設備(SaMD) 市場
    • 拉丁美洲、中東和非洲的醫療設備等其他軟體 (SaMD) 市場

第8章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第9章 公司簡介

  • MindMaze
  • Siemens
  • Biofourmis
  • BrightInsight, Inc.
  • 4S Information Systems Ltd,
  • Viz.ai, Inc.
  • F. Hoffmann-La Roche Ltd
  • Koninklijke Philips NV,
  • Orthogonal
  • Zuhlke Engineering AG
簡介目錄
Product Code: A323957

(SaMD) Software as a Medical Device Market

The (SaMD) software as a medical device market was valued at $19.5 million in 2023 and is projected to reach $96.2 million by 2033, growing at a CAGR of 17.3% from 2024 to 2033.

Software as a medical device (SaMD) is dedicated software designed for medical use through which functions are performed without the requirement of a hardware medical device. SaMD aids in managing patient health data, diagnosing health conditions, and recommending treatments. The software is highly versatile and accessible as it is easily accessible on general-purpose computing platforms such as smartphones and tablets. A key characteristic of SaMD is its potential to independently accomplish medical objectives, thereby accelerating the scope and efficiency of modern healthcare systems.

Increase in the adoption of telehealth and remote patient monitoring is a major driver of the (SaMD) software as a medical device market. In addition, support from several regulatory bodies such as the Food and Drug Administration and the European Union is boosting the demand for SaMD. To improve the healthcare providers' assistance, the incorporation of Clinical Decision Support Systems (CDSS) is an emerging trend in the market. The capabilities of CDSS help in making evidence-based clinical decisions, thereby enhancing diagnostic accuracy and optimizing treatment procedures.

However, the integration of existing medical records and healthcare data into SaMD is a time-consuming and costly process, hence hampering the development of the (SaMD) software as a medical device market. Furthermore, usage of the software is subject to rigorous regulatory compliance by the U.S. Food and Drug Administration (FDA), which presents significant challenges for the SaMD developers. The regulatory requirements of FDA include premarket approval, strict quality check, post-market surveillance, cybersecurity requirements, and specific software modifications & updates. All these requirements ensure the reliability and efficacy of SaMD, thus preventing compromise with critical health data and patient records.

Segment Review

The (SaMD) software as a medical device market is segmented into deployment type, application, end user, and region. On the basis of deployment type, the market is bifurcated into cloud based and on premise. Depending on application, it is divided into screening & diagnosis, monitoring & alerting, chronic disease management, digital therapeutics, and others. As per end user, it is classified into hospitals & clinics, home care settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of deployment type, the cloud-based segment dominates the (SaMD) software as a medical device market.

Depending on application, the screening & diagnosis segment accounts for a high market share.

As per end user, the hospitals & clinics segment acquires a high stake in the market.

Region wise, North America is the highest revenue generator in the (SaMD) software as a medical device market.

Competition Analysis

The major players operating in the global (SaMD) software as a medical device market include MindMaze , Siemens, Biofourmis, BrightInsight, Inc., 4S Information Systems Ltd, Viz.ai, Inc., F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Orthogonal, and Zuhlke Engineering AG. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Deployment Type

  • Cloud Based
  • On Premise

By Application

  • Screening and Diagnosis
  • Monitoring and Alerting
  • Chronic Disease Management
  • Digital Therapeutics
  • Others

By End User

  • Hospitals and Clinics
  • Home Care Settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • MindMaze
    • Siemens
    • Biofourmis
    • BrightInsight, Inc.
    • 4S Information Systems Ltd,
    • Viz.ai, Inc.
    • F. Hoffmann-La Roche Ltd
    • Koninklijke Philips N.V.,
    • Orthogonal
    • Zuhlke Engineering AG

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Deployment Type
  • 4.2. Cloud Based
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. On Premise
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Application
  • 5.2. Screening And Diagnosis
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Monitoring And Alerting
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Chronic Disease Management
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Digital Therapeutics
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Others
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals And Clinics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Home Care Settings
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Deployment Type
    • 7.2.3. Market Size and Forecast, By Application
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Software as a Medical Device (SaMD) Market
      • 7.2.6.1. Market Size and Forecast, By Deployment Type
      • 7.2.6.2. Market Size and Forecast, By Application
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Software as a Medical Device (SaMD) Market
      • 7.2.7.1. Market Size and Forecast, By Deployment Type
      • 7.2.7.2. Market Size and Forecast, By Application
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Software as a Medical Device (SaMD) Market
      • 7.2.8.1. Market Size and Forecast, By Deployment Type
      • 7.2.8.2. Market Size and Forecast, By Application
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Deployment Type
    • 7.3.3. Market Size and Forecast, By Application
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. Germany Software as a Medical Device (SaMD) Market
      • 7.3.6.1. Market Size and Forecast, By Deployment Type
      • 7.3.6.2. Market Size and Forecast, By Application
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. France Software as a Medical Device (SaMD) Market
      • 7.3.7.1. Market Size and Forecast, By Deployment Type
      • 7.3.7.2. Market Size and Forecast, By Application
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. UK Software as a Medical Device (SaMD) Market
      • 7.3.8.1. Market Size and Forecast, By Deployment Type
      • 7.3.8.2. Market Size and Forecast, By Application
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Italy Software as a Medical Device (SaMD) Market
      • 7.3.9.1. Market Size and Forecast, By Deployment Type
      • 7.3.9.2. Market Size and Forecast, By Application
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. Spain Software as a Medical Device (SaMD) Market
      • 7.3.10.1. Market Size and Forecast, By Deployment Type
      • 7.3.10.2. Market Size and Forecast, By Application
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Software as a Medical Device (SaMD) Market
      • 7.3.11.1. Market Size and Forecast, By Deployment Type
      • 7.3.11.2. Market Size and Forecast, By Application
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Deployment Type
    • 7.4.3. Market Size and Forecast, By Application
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. Japan Software as a Medical Device (SaMD) Market
      • 7.4.6.1. Market Size and Forecast, By Deployment Type
      • 7.4.6.2. Market Size and Forecast, By Application
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. China Software as a Medical Device (SaMD) Market
      • 7.4.7.1. Market Size and Forecast, By Deployment Type
      • 7.4.7.2. Market Size and Forecast, By Application
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Software as a Medical Device (SaMD) Market
      • 7.4.8.1. Market Size and Forecast, By Deployment Type
      • 7.4.8.2. Market Size and Forecast, By Application
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. Australia Software as a Medical Device (SaMD) Market
      • 7.4.9.1. Market Size and Forecast, By Deployment Type
      • 7.4.9.2. Market Size and Forecast, By Application
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. South Korea Software as a Medical Device (SaMD) Market
      • 7.4.10.1. Market Size and Forecast, By Deployment Type
      • 7.4.10.2. Market Size and Forecast, By Application
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Software as a Medical Device (SaMD) Market
      • 7.4.11.1. Market Size and Forecast, By Deployment Type
      • 7.4.11.2. Market Size and Forecast, By Application
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Deployment Type
    • 7.5.3. Market Size and Forecast, By Application
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Software as a Medical Device (SaMD) Market
      • 7.5.6.1. Market Size and Forecast, By Deployment Type
      • 7.5.6.2. Market Size and Forecast, By Application
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. Saudi Arabia Software as a Medical Device (SaMD) Market
      • 7.5.7.1. Market Size and Forecast, By Deployment Type
      • 7.5.7.2. Market Size and Forecast, By Application
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. South Africa Software as a Medical Device (SaMD) Market
      • 7.5.8.1. Market Size and Forecast, By Deployment Type
      • 7.5.8.2. Market Size and Forecast, By Application
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Software as a Medical Device (SaMD) Market
      • 7.5.9.1. Market Size and Forecast, By Deployment Type
      • 7.5.9.2. Market Size and Forecast, By Application
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. MindMaze
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Siemens
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Biofourmis
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. BrightInsight, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. 4S Information Systems Ltd,
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Viz.ai, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. F. Hoffmann-La Roche Ltd
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. Koninklijke Philips N.V.,
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Orthogonal
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments
  • 9.10. Zuhlke Engineering AG
    • 9.10.1. Company Overview
    • 9.10.2. Key Executives
    • 9.10.3. Company Snapshot
    • 9.10.4. Operating Business Segments
    • 9.10.5. Product Portfolio
    • 9.10.6. Business Performance
    • 9.10.7. Key Strategic Moves and Developments